Literature DB >> 17511849

The integrity of the blood-brain barrier in Alzheimer's disease.

A Algotsson1, B Winblad.   

Abstract

OBJECTIVE: To evaluate the integrity of the blood-brain barrier (BBB) in incident Alzheimer's disease (AD).
MATERIALS AND METHODS: The mean age of the 157 patients (45% men) was 69.7(9.4) years (range 51-88 years). The patients had undergone a thorough investigation including magnetic resonance imaging or computed tomography of the brain. The cerebrospinal(CSF)/plasma albumin ratio (albumin ratio) was used as a measure of BBB function.
RESULTS: There were gender differences with respect to albumin ratio and plasma creatinine with higher values in men (P < 0.001). 42% of the men and 13% of the women (P < 0.001) had a mild to moderate BBB dysfunction when applying the reference limit of the laboratory (<9.2). Both male gender (P = 0.002) and plasma creatinine (P = 0.009) were independently associated with the albumin ratio when controlling for putative confounders.
CONCLUSIONS: The BBB is dysfunctional in a portion of patients with AD, both women and, primarily, men. The dysfunction might influence the clearance of both harmful and beneficial substances across the barrier. Renal function might have an impact on the BBB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511849     DOI: 10.1111/j.1600-0404.2007.00823.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  26 in total

Review 1.  Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.

Authors:  Wei-Ye Liu; Zhi-Bin Wang; Li-Chao Zhang; Xin Wei; Ling Li
Journal:  CNS Neurosci Ther       Date:  2012-06-12       Impact factor: 5.243

Review 2.  Folate nutrition and blood-brain barrier dysfunction.

Authors:  Patrick J Stover; Jane Durga; Martha S Field
Journal:  Curr Opin Biotechnol       Date:  2017-02-10       Impact factor: 9.740

Review 3.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

Review 4.  Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS.

Authors:  Benjamin J Umlauf; Eric V Shusta
Journal:  Curr Opin Biotechnol       Date:  2019-03-05       Impact factor: 9.740

Review 5.  Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound.

Authors:  James J Choi; Shougang Wang; Truman R Brown; Scott A Small; Karen E K Duff; Elisa E Konofagou
Journal:  Ultrason Imaging       Date:  2008-07       Impact factor: 1.578

7.  A phenotypic change but not proliferation underlies glial responses in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Teresa Gómez-Isla; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Am J Pathol       Date:  2013-04-18       Impact factor: 4.307

Review 8.  Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.

Authors:  Michelle A Erickson; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

Review 9.  MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.

Authors:  Rajikha Raja; Gary A Rosenberg; Arvind Caprihan
Journal:  Neuropharmacology       Date:  2017-10-28       Impact factor: 5.250

10.  A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.

Authors:  Ronald J Holewinski; Zhicheng Jin; Matthew J Powell; Matthew D Maust; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-01-29       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.